comprehensive -WSS

comprehensive

author：hotspot 2025-09-28 15:21:01 - browse：43733

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: Zepbound, Valneva's vaccine, and more

WSS

Publishing genetic code of viruses could cause disaster

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

New chief aims to remake Sanofi Genzyme

How Brent Saunders' Allergan experiment failed

focus

comprehensive

explore

BioMarin wins approval for gene therapy to treat hemophilia A

Hey, doctors: Don't be no

In Memoriam: Notable people who died in 2023

Experimental asthma app from Apple and Anthem shows promise

Dobbs anniversary: the lost opportunity of abortion as health care

UnitedHealth sued over use of algorithm in Medicare Advantage plans

The cancer drug shortage isn’t new — and neither are the solutions

What is STAT's opinion section for?

Novavax promises a turnaround & Lilly roils the obesity market

Today's health inequities arise from racist U.S. history, say experts

hotspot

Ventyx halts psoriasis drug development after lackluster trial results

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Medicare’s new pay boost for primary care is angering specialists

Ohio still needs to do more to protect the right to abortion

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Readout Newsletter: Zepbound, Valneva's vaccine, and more

hotspot

hotspot

explore

Wikipedia